These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 15046605)

  • 1. The tumour suppressor PTEN: involvement of a tumour suppressor candidate protein in PTEN turnover.
    Maehama T; Okahara F; Kanaho Y
    Biochem Soc Trans; 2004 Apr; 32(Pt 2):343-7. PubMed ID: 15046605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pten signaling in gliomas.
    Knobbe CB; Merlo A; Reifenberger G
    Neuro Oncol; 2002 Jul; 4(3):196-211. PubMed ID: 12084351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute regulation of the tumour suppressor phosphatase, PTEN, by anionic lipids and reactive oxygen species.
    Downes CP; Walker S; McConnachie G; Lindsay Y; Batty IH; Leslie NR
    Biochem Soc Trans; 2004 Apr; 32(Pt 2):338-42. PubMed ID: 15046604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antagonism of PI 3-kinase-dependent signalling pathways by the tumour suppressor protein, PTEN.
    Downes CP; Bennett D; McConnachie G; Leslie NR; Pass I; MacPhee C; Patel L; Gray A
    Biochem Soc Trans; 2001 Nov; 29(Pt 6):846-51. PubMed ID: 11709086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PTEN up-regulates the tumor metastasis suppressor gene Drg-1 in prostate and breast cancer.
    Bandyopadhyay S; Pai SK; Hirota S; Hosobe S; Tsukada T; Miura K; Takano Y; Saito K; Commes T; Piquemal D; Watabe M; Gross S; Wang Y; Huggenvik J; Watabe K
    Cancer Res; 2004 Nov; 64(21):7655-60. PubMed ID: 15520163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The complexity of PTEN: mutation, marker and potential target for therapeutic intervention.
    Steelman LS; Bertrand FE; McCubrey JA
    Expert Opin Ther Targets; 2004 Dec; 8(6):537-50. PubMed ID: 15584861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting mutants of PTEN reveal distinct subsets of tumour suppressor functions.
    Leslie NR; Bennett D; Gray A; Pass I; Hoang-Xuan K; Downes CP
    Biochem J; 2001 Jul; 357(Pt 2):427-35. PubMed ID: 11439092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PTEN: a tumour suppressor that functions as a phospholipid phosphatase.
    Maehama T; Dixon JE
    Trends Cell Biol; 1999 Apr; 9(4):125-8. PubMed ID: 10203785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PTEN/MMAC1/TEP1 in signal transduction and tumorigenesis.
    Besson A; Robbins SM; Yong VW
    Eur J Biochem; 1999 Aug; 263(3):605-11. PubMed ID: 10469123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PTEN function: how normal cells control it and tumour cells lose it.
    Leslie NR; Downes CP
    Biochem J; 2004 Aug; 382(Pt 1):1-11. PubMed ID: 15193142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of androgen receptor signaling by PTEN (phosphatase and tensin homolog deleted on chromosome 10) tumor suppressor through distinct mechanisms in prostate cancer cells.
    Lin HK; Hu YC; Lee DK; Chang C
    Mol Endocrinol; 2004 Oct; 18(10):2409-23. PubMed ID: 15205473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of novel effectors of invasive cell growth downstream of phosphoinositide 3-kinase.
    Kaufmann J; Pronk G; Giese K; Klippel A
    Biochem Soc Trans; 2004 Apr; 32(Pt 2):355-9. PubMed ID: 15046608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutation and expression analysis of the putative prostate tumour-suppressor gene PTEN.
    Gray IC; Stewart LM; Phillips SM; Hamilton JA; Gray NE; Watson GJ; Spurr NK; Snary D
    Br J Cancer; 1998 Nov; 78(10):1296-300. PubMed ID: 9823969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of PTEN phosphorylation and stability by a tumor suppressor candidate protein.
    Okahara F; Ikawa H; Kanaho Y; Maehama T
    J Biol Chem; 2004 Oct; 279(44):45300-3. PubMed ID: 15355975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth-suppressive effects of BPOZ and EGR2, two genes involved in the PTEN signaling pathway.
    Unoki M; Nakamura Y
    Oncogene; 2001 Jul; 20(33):4457-65. PubMed ID: 11494141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PTEN and myotubularin: novel phosphoinositide phosphatases.
    Maehama T; Taylor GS; Dixon JE
    Annu Rev Biochem; 2001; 70():247-79. PubMed ID: 11395408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The tumour-suppressor function of PTEN requires an N-terminal lipid-binding motif.
    Walker SM; Leslie NR; Perera NM; Batty IH; Downes CP
    Biochem J; 2004 Apr; 379(Pt 2):301-7. PubMed ID: 14711368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MMAC/PTEN tumor suppressor gene regulates vascular endothelial growth factor-mediated angiogenesis in prostate cancer.
    Koul D; Shen R; Garyali A; Ke LD; Liu TJ; Yung WK
    Int J Oncol; 2002 Sep; 21(3):469-75. PubMed ID: 12168088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastrin-releasing peptide-induced down-regulation of tumor suppressor protein PTEN (phosphatase and tensin homolog deleted on chromosome ten) in neuroblastomas.
    Qiao J; Kang J; Cree J; Evers BM; Chung DH
    Ann Surg; 2005 May; 241(5):684-91; discussion 691-2. PubMed ID: 15849504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Genes & cancer. Card no. 28: PTEN (MMAC, TEP-1) (phosphatase and tensin homolog deleted on chromosome 10)].
    Soussi T
    Bull Cancer; 1999 Sep; 86(9):715-6. PubMed ID: 10576807
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.